#GUANGZHOU

Guangzhou International Biotech Island (GIBI), formerly known as Guanzhou Island (or Dove Island), is located in the center of the Pearl River in the southeast of Haizhu district, Guangzhou. It is an elliptical island lying in a northeast-southwest direction, to the east of Guanzhou waterway and to the west of Luntou waterway. Covering an area of 183.18 hectares, GIBI is the hinterland of biomedical research and development in Guangzhou Development District (GDD) and of the biomedical industry in the strategic layout of "one river-three belts" of the city. The core location of the National Biological Industry Base of Guangzhou approved by the National Development and Reform Commission, of the Guangzhou-Shenzhen Science and Technology Innovation Corridor, and of the Guangdong-Hong Kong-Macao Greater Bay Area, GIBI plans to be the regional headquartersr, operation center and R&D center of domestic and foreign biomedical and health enterprises as well as a world-class biomedicine innovation base and Guangdong innovation-driven development demonstration area.
In 1999, the municipal committee of the municipal government proposed to build Guangzhou Island into an international biotech research and industrial base. In 2000, the project and the name Guangzhou International Biotech Island were approved by the National Planning Commission, and in 2008 the project was accredited as the key part of the Outline for Reform and Development Planning of Pearl River Delta. By the beginning of 2016, GIBI had turned out to be the heart of the three strategic transportation hubs mode and the one river-two banks-three belts concept. In 2017, it was listed as one of the 13 innovation nodes of Guangzhou in the Guangzhou-Shenzhen Science and Technology Innovation Corridor plan, and at the same time became the permanent home of Guanzhou International Bio Forum.
GIBI intends to build up six functional areas of biotechnology R&D, high-end manufacturing, corporate headquarters, public service, recreation, and supporting services. Some pillar industry sections, such as drug development, stem cell and regenerative medicine, precision medicine, large health management consulting, and medical devices have been preliminarily completed.
Fully finished are some business projects such as GIBI standard property units 1-3, GIBI hotels, the Guangzhou international life science innovation center, and an enterprise headquarters community. Projects under construction include standard property unit 4 and projects of Yishan Biotechnology corporation, Yipinhong Pharmaceutical corporation, EagleStaR, Chuangjing Property, and the Guangzhou General Pharmaceutical Research Institute.

[@GagikDavtyan757]

Well done

[@artaksargsyan2339]

Absolutely mind-blowing!
Green Biotech Island's self-driving bus showcases how technology can revolutionize public transport.
Can't help but feel excited about what's to come in the world of autonomous vehicles

[@armenvardanyan9200]

,👍👍👍

[@aezakmi98]

🔥🔥🔥

[@ArsenFox-h6p]

China amazes 👍🏻

[@DoingBusinesswithChina]

For almost a decade!!

[@SilvaAraqelyan-o5n]

👍👍👍👏👏👏🎉

[@DoingBusinesswithChina]

Thanks for your opinion!!

[@AsaturArakelyan]

❤❤❤❤

[@TheBest-oe6po]

Insane!! 😂😂😂

[@narek11]

A bit scary 😄

[@DoingBusinesswithChina]

I understand your meaning
But all good unless we control AI, not Vise Versa

[@mikefarrell5530]

Always thought that Tesla is gonna be the pioneer in this type of busses as well!! Now China is again ahead????

[@DoingBusinesswithChina]

China is already the pioneer in a lot of stuff!!!

[@DoingBusinesswithChina]

@RASHID_KURABEGOV This is just experiment

[@ArsenFox-h6p]

Not for kz 😬

[@DoingBusinesswithChina]

Why??

[@AsaturArakelyan]

❤❤❤

[@DoingBusinesswithChina]

Thanks my dear viewer!!!